SC
Squadron Capital Management LLC disclosed a 7.3% stake in ZNTL
Squadron Capital Management LLC reported owning 7.3% of Zentalis Pharmaceuticals, Inc. (ZNTL) (6,927,905 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G